Yanhua Liang | Signal Transduction Mechanisms | Best Researcher Award

Published on by Cell Biologist

Prof. Yanhua Liang | Signal Transduction Mechanisms | Best Researcher Award

Prof. Yanhua Liang, Shenzhen Hospital of Southern Medical University, China

Dr. Yan-Hua Liang,  is a distinguished dermatologist, academic, and researcher. He serves as Chairman and Chief Physician in the Department of Dermatology at Shenzhen Hospital, Southern Medical University. With over two decades of clinical and research experience, he is widely recognized for his contributions to dermatological science and translational medicine. Dr. Liang holds dual PhDs and has trained internationally, including a postdoctoral fellowship at The Jackson Laboratory in the U.S. His commitment to advancing psoriasis therapy, dermatological immunology, and healthcare system improvements is evident in his prolific publication record and mentorship roles. He actively collaborates with global experts and consistently publishes in high-impact journals. Through a career grounded in clinical excellence and research innovation, Dr. Liang continues to shape the field of dermatology in China and beyond.\

Publication Profile: 

Scopus

Strengths for the Award

  1. Proven Academic Excellence

    • Holds M.D., dual Ph.D.s, and completed a prestigious postdoctoral fellowship at The Jackson Laboratory, USA — reflecting strong scientific and international credentials.

  2. Clinical Leadership & Longstanding Experience

    • Over 20 years in dermatology, currently serving as Chairman and Chief Physician at a major university-affiliated hospital.

  3. Research Output & Innovation

    • 10+ high-quality peer-reviewed publications (2023–2025) in leading journals like Scientific Reports, Drug Safety, Frontiers in Medicine, and Dermatology.

    • Focus on real-world studies, biologic therapies, psoriasis, autoimmune skin diseases, and translational dermatology — addressing clinically relevant problems.

  4. Mentorship and Academic Contributions

    • Active Ph.D. supervisor, guiding the next generation of dermatological researchers.

    • Collaborates with both domestic and international institutions, boosting China’s contribution to global dermatology research.

  5. Multidisciplinary Impact & Public Health Relevance

    • Involved in infectious disease preparedness (Monkeypox) and healthcare system education for medical professionals.

Areas for Improvement

  1. International Visibility & Awards

    • While the academic record is strong, international keynote roles, global society leadership, or major global awards are not yet highlighted. These would further elevate his candidacy.

  2. Broader Interdisciplinary Integration

    • Could explore collaborative work in AI-driven dermatology, digital diagnostics, or bioinformatics, which are emerging fields in skin science.

Education (150 words)

Dr. Liang’s academic journey reflects a steadfast pursuit of medical excellence. He earned his Bachelor of Medicine from Gannan Medical University (1996–2001), followed by a Master of Science and Ph.D. in Dermatology from Anhui Medical University (2001–2007). To further enrich his scientific acumen, he completed a Postdoctoral Fellowship at The Jackson Laboratory, USA (2007–2010), a premier institution for biomedical research. His education combines strong clinical training with rigorous research methodology, particularly in genetics and dermatological sciences. Dr. Liang’s dual PhDs signify his interdisciplinary focus and commitment to integrating basic science into clinical innovation. His international training has enabled him to bridge Eastern and Western medical practices and adopt a global perspective in addressing skin diseases. With a strong foundation in immunodermatology, translational medicine, and evidence-based treatments, Dr. Liang’s academic background is a cornerstone of his success as a clinician-scientist and mentor.

Experience (150 words)

Dr. Yan-Hua Liang has over 20 years of experience in clinical dermatology and academic leadership. He currently holds the title of Chairman and Professor at the Department of Dermatology, Shenzhen Hospital, Southern Medical University (since 2016). Prior to this, he was a Professor at Nanfang Hospital, also part of Southern Medical University (2012–2015). His clinical expertise spans psoriasis, atopic dermatitis, and autoimmune skin diseases, with a focus on biologic therapies and translational dermatology. He has treated thousands of patients and led major clinical trials in China. As a Ph.D. supervisor, Dr. Liang has mentored numerous postgraduate students and emerging researchers. His leadership has helped modernize dermatological practices, elevate research standards, and foster international collaborations. Recognized for his medical innovations and deep patient care, Dr. Liang stands out as a thought leader in dermatology in the Greater Bay Area and nationally.

Research Focus (150 words)

Dr. Liang’s primary research interests lie in psoriasis treatment, immunodermatology, and translational skin research. He is a pioneer in real-world data analysis of biologic therapies for psoriasis, as demonstrated in several of his prospective, multicenter studies. His focus also includes the gut-skin axis, autoimmune dermatoses, and health policy studies aimed at improving access to dermatological care. In recent years, he has expanded his work into emerging infectious diseases like monkeypox, integrating public health into clinical dermatology. His work is often collaborative, involving multi-disciplinary teams and cross-border research. Dr. Liang is especially committed to improving healthcare delivery systems in dermatology, with a unique emphasis on evidence-based treatment, quality of life metrics, and healthcare worker training. His future focus aims to further explore microbiome-immune interactions in skin disease and introduce AI-driven diagnostic support systems. His research portfolio aligns with global dermatological priorities, positioning him as a leader in innovation and care.

Publications – One-line Format with Emojis

  1.  Cutaneous and systemic improvements in psoriasis after biologics in real-world study – Scientific Reports, 2025

  2.  Gut microbiota and psoriasis: A systematic review – Eur J Pharmacol, 2025

  3.  Hereditary Angioedema in China: Awareness and Advocacy from Greater Bay to Global – Clin Exp Allergy, 2025

  4.  Healthcare workers’ monkeypox knowledge and confidence survey – World J Clin Cases, 2025

  5.  Reducing recurrence of Condyloma Acuminatum via lesional auto-transplantation – J Cosmetics, Dermatol Sci Appl, 2024

  6.  Atopic Dermatitis: From Bench to Bedside – Front Med, 2024

  7.  Ixekizumab safety in Chinese plaque psoriasis patients – 12-week observational study – Drug Saf, 2024

  8. Effectiveness of Ixekizumab in special area involvement psoriasis patients – Dermatol Ther (Heidelb), 2024

  9. Quality of life and predictors of complete skin clearance in psoriasis – Dermatology, 2023

  10. Ixekizumab safety and efficacy in Chinese psoriasis patients – Prospective real-world study – Adv Ther, 2023

Conclusion

Dr. Yan-Hua Liang is a highly accomplished clinician-scientist whose integrated focus on clinical excellence, academic mentorship, and research productivity positions him as a leading candidate for the Best Researcher Award. His commitment to real-world research, particularly in psoriasis and biologic therapy, is both impactful and timely.

Given his sustained contributions, ongoing innovative work, and national academic leadership, Dr. Liang exemplifies the qualities of a modern, translational researcher who is significantly advancing dermatology in China and beyond.

Hannah Wen | Breast Cancer | Best Researcher Award

Published on by Cell Biologist

Dr. Hannah Wen | Breast Cancer | Best Researcher Award

Dr. Hannah Wen, MEMORIAL SLOAN KETTERING CANCER CENTER, United States

Dr. Hannah Y. Wen, M.D., Ph.D., is a distinguished breast cancer pathologist and cancer researcher at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. With dual training in medicine and cancer biology, Dr. Wen’s career reflects a deep commitment to advancing the field of translational oncology. Her research focuses on triple-negative breast cancer (TNBC), rare breast tumor subtypes, and predictive/prognostic biomarkers. Dr. Wen is a prolific academic contributor with publications in high-impact journals such as Nature Communications and Cancer Research. She integrates molecular biology with diagnostic pathology to improve cancer stratification and therapy decisions. In addition to her investigative work, she contributes as a principal investigator on multiple IRB-approved studies at MSKCC. Recognized with early academic accolades and continuously advancing the frontiers of cancer pathology, Dr. Wen exemplifies the blend of scientific rigor and clinical relevance. She is a strong candidate for any prestigious research award in pathology and oncology.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Academic Training
    Dr. Wen holds an M.D. from Peking University Health Science Center, one of China’s top medical schools, and a Ph.D. in Cancer Biology from MD Anderson Cancer Center, a global leader in cancer research.

  2. Robust Postdoctoral and Clinical Research Experience
    Her postdoctoral work at Genentech Inc. and ongoing clinical-scientific role at Memorial Sloan Kettering Cancer Center (MSKCC) place her at the intersection of innovative molecular research and high-impact clinical diagnostics.

  3. High-Impact Publications
    She has authored landmark papers in journals like Cancer Research, Nature Cell Biology, PNAS, Modern Pathology, and Nature Communications, covering diverse areas such as:

    • Triple-negative breast cancer

    • Genetic markers (e.g., BRCA1, p202)

    • Molecular subtyping of rare breast tumors

    • Pathologic stratification of early-stage breast cancer

  4. Active Investigator and IRB Leadership
    Dr. Wen is Principal Investigator for multiple MSK IRB protocols involving rare breast cancer subtypes and molecular markers. This shows strong leadership in translational research.

  5. Recognition and Consistency
    From receiving Top 10 Student Awards in Beijing to leading diagnostic-pathologic breakthroughs in 2025, her excellence spans over three decades.

Areas for Improvement:

  1. Visibility of Awards in the U.S. Academic System
    While her early academic awards are impressive, more documented recent honors, society memberships, or fellowships could further enhance her candidacy.

  2. Mentorship and Teaching Roles
    While likely involved, specific mention of mentorship, educational leadership, or curriculum development would strengthen her profile in academic impact.

  3. Interdisciplinary Collaborations
    Explicit examples of cross-disciplinary collaborations (e.g., computational oncology, AI in pathology) would underscore her innovation potential in modern biomedical research.

Education:

Dr. Hannah Y. Wen obtained her M.D. from Peking University Health Science Center, Beijing, China (1988–1993), where she was consistently recognized as an outstanding student. She pursued her Ph.D. in Cancer Biology at the University of Texas Health Science Center/MD Anderson Cancer Center in Houston, TX (1997–2001), focusing on molecular oncology. During her Ph.D., she contributed significantly to understanding interferon-inducible proteins in cancer suppression. Her educational journey reflects deep interdisciplinary training, combining clinical medicine with cutting-edge research. This robust academic background has laid the foundation for her success in translational cancer research and diagnostic pathology. Dr. Wen’s training continues with postdoctoral work at Genentech Inc. in Experimental Pathology, which further honed her molecular diagnostic skills. Her global academic trajectory—from China to elite U.S. institutions—has shaped her into a well-rounded researcher capable of addressing complex challenges in breast cancer diagnosis and treatment.

Experience:

Dr. Wen brings over two decades of research and clinical experience in cancer biology and diagnostic pathology. After completing her Ph.D. at MD Anderson Cancer Center, she conducted postdoctoral research in Experimental Pathology at Genentech, Inc., South San Francisco (2002–2003). Since then, she has held a faculty position at the Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center. At MSKCC, Dr. Wen has served as Principal Investigator on multiple IRB-approved protocols investigating rare breast cancer subtypes and genetic alterations. Her daily work bridges histopathology and genomics to advance precision medicine in breast cancer. Beyond research, she mentors fellows and contributes to academic committees, reinforcing her role as a leader in her field. Her hands-on experience with triple-negative breast cancer, breast tumor markers, and breast pathology variants gives her a rare clinical-research dual expertise, making her a vital figure in contemporary breast cancer diagnostics.

Awards and Honors:

Dr. Hannah Y. Wen has received numerous recognitions throughout her academic journey. Early in her career, she was honored with the Outstanding Student Award by Peking University Health Science Center (1988–1992), a distinction granted to top-tier medical students. She was also named among Beijing’s Top 10 Outstanding Students in 1992, recognizing her academic and leadership excellence. While formal awards during her U.S. career are not extensively documented in the data provided, Dr. Wen’s growing impact in high-impact journals and role as a Principal Investigator at MSKCC are implicit accolades in the competitive world of academic medicine. Her contributions to translational breast cancer research, including studies on BRCA1 inactivation and tumor progression markers, underscore her continuous excellence. Given her record of impactful research and professional standing at one of the world’s leading cancer centers, she remains a strong contender for recognition such as the Best Researcher Award.

Research Focus:

Dr. Wen’s research centers on triple-negative breast cancer (TNBC), a challenging and aggressive subtype of breast cancer with limited therapeutic targets. She also investigates rare and under-recognized breast tumor subtypes such as microglandular adenosis, acinic cell carcinoma, and tall cell carcinoma with reversed polarity. Her work involves the identification of predictive and prognostic markers, employing techniques such as targeted gene sequencing, BRCA1 methylation analysis, and molecular stratification models. As Principal Investigator, she leads studies under MSK IRB Protocols #16-411 and #16-596, exploring the genomic and epigenetic landscape of TNBC. Her research stands out for its clinical translation, directly impacting patient diagnosis and treatment planning. Recent contributions to Nature Communications and Modern Pathology show her innovative use of multimodal histopathological models and molecular profiling. Dr. Wen’s research reflects a powerful blend of diagnostic pathology, molecular genetics, and precision oncology—positioning her as a leader in breast cancer research.

Publications Top Notes:

  1.  The Role of Platelet Activating Factor in Reproduction – Progress of Anatomical Sciences (1996)

  2.  Transforming Growth Factor-α and Its Receptor in Reproduction – Medical Sciences (1997)

  3.  TGF-α Expression in Mouse Embryos and Uterus – J. Beijing Medical Univ. (1997)

  4.  p202 Slows Prostate Cancer Cell Growth – Oncogene (1999)

  5.  p202 Enhances TNF-α-Induced Apoptosis in Breast Cancer – Cancer Research (2000)

  6.  β-catenin as a Prognostic Marker in Breast Cancer – PNAS USA (2000)

  7.  HER-2/neu Drives Androgen-Independent Prostate Cancer – Cancer Research (2000)

  8.  EGFR’s Nuclear Role as a Transcription Factor – Nature Cell Biology (2001)

  9.  p202 Mediates Anti-Tumor Activity in Pancreatic Cancer – Cancer Research (2001)

  10.  Systemic Tumor Suppression via Bik Gene – Cancer Research (2002)

Conclusion:

Dr. Hannah Y. Wen is a highly qualified and deserving nominee for the Best Researcher Award. Her outstanding academic background, consistent and impactful research output, and leadership in breast cancer pathology make her a top-tier researcher in the field of translational oncology. She excels in integrating molecular biology with diagnostic pathology to improve cancer detection, stratification, and treatment.

With minor enhancements in visibility and cross-disciplinary leadership, Dr. Wen is not only suitable but a model candidate for this award. Her work is advancing breast cancer care at both the bench and bedside—fulfilling the core mission of research excellence.

Xingle Zhao | Gene Therapy of Hearing Loss | Best Researcher Award

Published on by Cell Biologist

Dr. Xingle Zhao | Gene Therapy of Hearing Loss | Best Researcher Award

Dr. Xingle Zhao, The First Affiliated Hospital of Zhengzhou University, China

Dr. Xingle Zhao is a dedicated biomedical researcher with a Ph.D. in Surgery from Shanghai Jiaotong University, focusing on inner ear gene therapy. With a robust academic foundation from Wuhan University and a research journey spanning over a decade, he has contributed significantly to auditory neuroscience. His groundbreaking work in cochlear gene therapy has led to several high-impact publications, including in Nature Communications and Human Gene Therapy. Dr. Zhao’s research centers on advancing therapeutic interventions for hearing loss using adeno-associated virus (AAV)-mediated gene delivery and CRISPR-based editing in murine models. Passionate about translating research into clinical potential, he is recognized for his innovative strategies to restore auditory function. His commitment to excellence and innovation places him as a strong candidate for the Best Researcher Award.

Publication Profile: 

Orcid

 Strengths for the Award:

  1.  Strong Publication Record in High-Impact Journals
    Dr. Zhao has published in top-tier journals such as Nature Communications, Human Gene Therapy, and Molecular Therapy – Methods & Clinical Development. This reflects both the scientific significance and rigor of his work.

  2.  Niche Yet Impactful Research Focus
    His expertise in gene therapy for inner ear disorders is highly specialized and innovative. His work directly contributes to addressing sensorineural hearing loss, a critical unmet medical need.

  3.  Technical Mastery and Innovation
    Dr. Zhao demonstrates advanced skills in using AAV-mediated gene delivery, CRISPR/Cas9, transcriptomic analysis, and base editing—technologies at the forefront of molecular medicine.

  4.  Collaborative Researcher
    He has successfully collaborated with multiple research teams and institutions, showing strong team science orientation, often essential in translational biomedical research.

  5.  Translational Impact
    His research moves beyond basic science to show real therapeutic potential, such as day-one hearing restoration in adult deaf mice using AAV8-mediated Vglut3 rescue—a milestone in preclinical gene therapy.

Areas for Improvement:

  1.  Limited International Exposure
    While his work is high quality, more international collaborations or fellowships could increase his global visibility and broaden the impact of his research.

  2.  Public and Clinical Translation Pathways
    A focus on translating findings into clinical trials, and greater involvement in science communication or patent filings, would enhance the practical application of his discoveries.

  3.  Mentorship and Outreach
    Expanding roles in mentorship, teaching, or scientific leadership could amplify his influence and contribute to academic community-building.

Education:

Dr. Xingle Zhao completed his Ph.D. in Surgery at Shanghai Jiaotong University (2017–2023), where he specialized in gene therapy for inner ear disorders. His doctoral research led to a series of influential publications, pushing forward the understanding and treatment of sensorineural hearing loss through genetic strategies. He focused on AAV vector development, gene editing, and functional restoration in animal models. Prior to his doctoral studies, he earned his Bachelor’s degree in Surgery at Wuhan University (2012–2017). There, he built a solid clinical and anatomical foundation, gaining early exposure to surgical principles and developing core competencies in patient care. His academic training combined cutting-edge biomedical research with real-world medical applications, enabling him to bridge laboratory findings with translational potential. Dr. Zhao’s educational background is rooted in two of China’s leading institutions, reinforcing both his technical rigor and academic integrity.

Experience:

Dr. Xingle Zhao brings a decade of experience in gene therapy and auditory neuroscience. During his Ph.D. at Shanghai Jiaotong University, he led and co-authored multiple studies on cochlear gene editing and therapeutic restoration in mouse models, particularly targeting genes such as Vglut3 and Otoferlin. He has hands-on expertise in AAV vector design, CRISPR-Cas9 technologies, in vivo cochlear injection, and molecular analysis. His role extended from lab-based research to collaborative team science, working with clinicians, molecular biologists, and geneticists across disciplines. Notably, he contributed to a high-impact Nature Communications paper and published in Human Gene Therapy and Hearing Research. Dr. Zhao also demonstrated mentoring capacity with junior researchers and was actively involved in presenting his work at scientific forums. His experience spans preclinical experimentation, data interpretation, and translational strategies, making him highly proficient in targeted gene therapy development for hearing restoration.

Research Focus:

Dr. Xingle Zhao’s research is centered on genetic therapies for hearing loss, with an emphasis on restoring auditory function via gene delivery systems. His work focuses on the development and application of adeno-associated virus (AAV) vectors, CRISPR/Cas9 editing tools, and promoter optimization for inner ear gene targeting. A particular emphasis is placed on rescuing hearing loss in adult and neonatal mouse models, notably targeting genes such as Vglut3 and Otof. His research highlights the potential of rapid gene therapy as a practical intervention in auditory impairment, bridging basic science with potential clinical treatments. Dr. Zhao also investigates the transcriptomic diversity of cochlear genes, uncovering isoform-specific roles in auditory physiology. His vision is to enable safe, efficient, and long-lasting gene therapy protocols that can be translated into future human therapies for sensorineural deafness. This niche yet impactful domain places him at the forefront of auditory gene therapy innovation.

Publication Top Notes: 

  1.  Cochlear transcript diversity and its role in auditory functions implied by an otoferlin short isoform – Nature Communications (2023)

  2.  Gene Therapy Restores Auditory Functions in an Adult Vglut3 Knockout Mouse Model – Human Gene Therapy (2022)

  3.  Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae – Hearing Research (2020)

  4.  Adeno-associated virus vector enables safe and efficient Cas9 activation in neonatal and adult Cas9 knock-in murine cochleae – Gene Therapy (2020)

  5.  Gene editing-based hearing impairment research and therapeutics – Neuroscience Letters (2019)

  6.  A review of application of base editing for the treatment of inner ear disorders – Journal of Bio-X Research (2019)

  7.  Rapid Cochlear Gene Therapy in Adult Deaf Mice: Vglut3 Rescue via AAV8 Achieves Day-1 Hearing Restoration – Molecular Therapy Methods & Clinical Development (2025)

Conclusion:

Dr. Xingle Zhao is a highly suitable candidate for the Best Researcher Award. His impactful work in gene therapy, focused on restoring hearing through precise molecular interventions, represents a significant scientific advancement with strong translational promise. He brings together academic rigor, innovation, and collaboration—hallmarks of a leading biomedical researcher. While expanding global collaboration and clinical engagement could further strengthen his profile, his current contributions already position him as a rising star in auditory genetics and molecular therapeutics.

Chetan Shinde | Genetics and Plant Breeding | Young Scientist Award

Published on by Cell Biologist

Mr. Chetan Shinde | Genetics and Plant Breeding | Young Scientist Award

Mr. Chetan Shinde, Mahatma Phule Krishi Vidyapeeth, Rahuri, India

Mr. Shinde Chetan Subhash is a dedicated and passionate agricultural researcher from India with a strong academic foundation and significant contributions to plant genetics and breeding. Known for his positive thinking, excellent presentation skills, and remarkable stage courage, he has demonstrated leadership from his undergraduate days, including his involvement in NSS and technical councils. With a keen interest in crop improvement and biotechnology, Mr. Shinde has co-authored two books and published over 15 peer-reviewed research articles in reputed journals. His work focuses on genetic diversity, molecular characterization, and breeding strategies for crops like soybean, rice, and millet. He shows great promise as a young scientist committed to advancing agricultural innovation. His academic excellence, practical exposure, and publication record make him a valuable contributor to the scientific community.

Publication Profile: 

Google scholar

Strengths for the Award:

  1. Outstanding Academic Performance

    • Secured 89.60% in M.Sc. (Agri.) and 88.70% in B.Sc. (Agri.), both with First Class Distinction from prestigious institutes under Mahatma Phule Krishi Vidyapeeth, Rahuri.

  2. Robust Research Publication Profile

    • Co-authored 15+ research articles in reputed, peer-reviewed national and international journals.

    • Authored 2 academic books on Plant Breeding and Genetics and Biotic Stress Resistance, published by respected publishers.

  3. Diverse and Applied Research Focus

    • Research spans crop improvement, genetic diversity, molecular marker-assisted selection, stress resistance, and microbial consortia, with applications to rice, soybean, pearl millet, finger millet, and moringa.

  4. Technical and Leadership Engagement

    • Served as an NSS volunteer and participated in rural development activities.

    • Member of the All India Council for Technical Skill Development, reflecting commitment to national agricultural capacity building.

  5. Professional Strengths

    • Demonstrates positive thinking, presentation skills, and stage courage—key traits for academic dissemination and leadership in research.

Areas for Improvement:

  1. Global Exposure & Collaborations

    • Can benefit from engaging in international conferences, research networks, or joint publications to enhance global scientific presence.

  2. Advanced Data Analytics

    • Opportunity to deepen skills in bioinformatics, genomics data analysis, and AI applications in plant breeding for future-ready research.

  3. Research Commercialization or Field Application

    • Encouraged to explore technology transfer, patent filings, or on-ground trials that connect his research to real-world farming outcomes.

Education:

Mr. Shinde Chetan Subhash holds an M.Sc. (Agri.) in Genetics and Plant Breeding (2022) from the College of Agriculture, Pune, under Mahatma Phule Krishi Vidyapeeth, Rahuri, securing 89.60% with first class distinction. He earned his B.Sc. (Agri.) in 2020 from Shramashakti College of Agriculture, Maldad, also affiliated with MPKV Rahuri, graduating with 88.70% and first class with distinction. His strong academic record is complemented by active co-curricular participation, including serving as an NSS volunteer and engaging in technical skill development activities. Throughout his academic career, he has consistently excelled in both theoretical and practical aspects of agricultural science. His education has laid a solid foundation for his current research pursuits in crop genetics, plant breeding, and biotechnology, with a specific interest in improving genetic traits and addressing challenges related to biotic stress in crops.

Experience:

Mr. Shinde has an impressive background in both academic and applied agricultural research. During his M.Sc. and B.Sc. studies, he gained hands-on experience in field trials, molecular marker analysis, and statistical evaluation of crop performance. His involvement in multiple research projects has allowed him to collaborate with reputed scientists across India. He has actively participated in NSS rural development programs and is a member of the All India Council for Technical Skill Development. Mr. Shinde’s practical experience is evident from his diverse publication portfolio, including topics on genetic variability, microbial consortia, land use implications, and drought tolerance in crops. His contributions span both classical breeding techniques and modern molecular tools. He has also co-authored two books on plant breeding and biotic stress resistance, showcasing his versatility and scholarly engagement. He is well-prepared for independent research and future leadership in plant science innovation.

Research Focus:

Mr. Shinde’s research is centered on Genetics and Plant Breeding, with an emphasis on improving crop performance under stress conditions. His work spans molecular characterization, development of microbial consortia for nutrient management, and genetic diversity analysis in major crops like rice, soybean, pearl millet, drumstick, and finger millet. He utilizes classical breeding methods and integrates modern biotechnological approaches, including marker-assisted selection. His interest in drought tolerance, biotic stress resistance, and sustainable crop productivity addresses critical agricultural challenges. Notably, he has contributed to molecular research on Kunitz Trypsin Inhibitor and lipoxygenase genes in soybean, ecological land use dynamics, and nutrient optimization in legumes. Through interdisciplinary collaboration, Mr. Shinde has positioned himself at the forefront of agricultural innovation. His work is aligned with the goals of food security, climate resilience, and genetic conservation. He aspires to contribute further to national and global agricultural research as a young scientist.

Publications Top Notes: 

  1. 📘 Plant Breeding and Genetics: Present Concepts and Approaches – Volume 2 (Book)

  2. 📗 Biotic Stress Resistance in Horticultural Crops (Book)

  3. 📝 Evaluation of Wheat [Triticum aestivum (L.)] Genotypes in Response to Late Sown Conditions

  4. 🌱 Development of Microbial Consortia for Nutrient Supplementation to Chickpea

  5. 🌍 Ecological Implications of Land Use Dynamics in Western Maharashtra

  6. 🌾 Estimation of Genetic Variability in Pearl Millet (Pennisetum glaucum L.)

  7. 🌿 Association of Characters and Path Coefficient Analysis in Fodder Drumstick

  8. 🌾 Evaluation of Genetic Divergence in Rice (Oryza sativa L.) Genotypes

  9. 🧬 Identification of Soybean Segregants for Kunitz and Lipoxygenase Genes via Molecular Markers

  10. 🌱 Genetic Variability Studies in Fodder Drumstick (Moringa oleifera L.)

Conclusion:

Mr. Shinde Chetan Subhash is highly suitable for the Research for Young Scientist Award. His academic excellence, multi-dimensional research contributions, and commitment to agricultural innovation strongly align with the award’s purpose—to encourage and recognize emerging researchers. His work bridges traditional breeding and modern biotechnology with a clear focus on sustainable and productive agriculture.

With continued mentorship and strategic research direction, he holds the potential to become a leading young scientist in India’s agri-biotech and crop improvement ecosystem.

Subhani Okarvi | Molecular Imaging | Innovative Research Award

Published on by Cell Biologist

Prof. Dr. Subhani Okarvi | Molecular Imaging | Innovative Research Award

Prof. Dr. Subhani Okarvi, KFSHRC, Saudi Arabia

Dr. Subhani Mohammad Okarvi is a distinguished Senior Medical Scientist and Section Head of the Cyclotron and Radiopharmaceuticals Department at King Faisal Specialist Hospital and Research Centre. With over three decades of expertise in radiopharmaceutical sciences, Dr. Okarvi has significantly contributed to the design, synthesis, and evaluation of novel radiolabeled peptides for cancer diagnostics and therapy. His pioneering research focuses on developing peptide-based agents labeled with radionuclides like ⁶⁸Ga, ¹⁷⁷Lu, and ⁸⁹Zr, which aid in targeting tumors such as breast and ovarian cancers. Dr. Okarvi is internationally recognized through numerous publications and collaborative efforts that enhance nuclear medicine applications in oncology. His commitment to translational research and quality control in clinical radiopharmaceutical production makes him an invaluable asset to the scientific community.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Pioneering Research in Radiopharmaceuticals
    Dr. Okarvi has made significant and sustained contributions to the field of radiopharmaceutical sciences, particularly in the development of peptide-based radiotracers for cancer imaging and therapy.

  2. Innovation in Peptide Engineering
    He has developed and evaluated numerous novel radiolabeled peptides, including agents targeting estrogen receptors, Mucin1, Folate receptors, and integrins, demonstrating originality in design and clinical relevance.

  3. Multidisciplinary Integration
    His work intersects medicinal chemistry, molecular biology, and nuclear medicine, showing strong translational value from bench to bedside.

  4. High-Impact Publications
    With over 15 peer-reviewed journal articles (many in leading journals such as EJNMMI Radiopharmacy and Chemistry, Cancer Biotherapy and Radiopharmaceuticals, and Molecules), his research is widely recognized and cited.

  5. Leadership in Clinical Translation
    At King Faisal Specialist Hospital and Research Centre, he leads the production and quality control of clinically used radiopharmaceuticals (⁹⁹ᵐTc, ⁶⁸Ga, ¹⁷⁷Lu, ⁸⁹Zr), reflecting real-world healthcare impact.

  6. International Recognition
    His fellowships from Katholieke Universiteit Leuven and the Alberta Cancer Board, and his collaborative work across borders, reflect international appreciation of his contributions.

Areas for Improvement:

  1. Patent & Commercialization Activity
    While Dr. Okarvi’s research has strong translational potential, more structured efforts in patenting and commercializing his peptide constructs would broaden their impact.

  2. Broader Interdisciplinary Outreach
    Collaborations with AI, data science, and theranostic platforms could elevate the reach of his innovations in the next phase of precision medicine.

  3. Global Thought Leadership
    Increased participation as a keynote speaker, panelist, or editorial board member in international forums would boost his visibility and influence within the scientific community.

Education:

Dr. Subhani M. Okarvi’s academic journey began with a Bachelor’s in General Sciences (1984) and Pharmacy (1986) from the University of Karachi, Pakistan. He further pursued advanced studies in Europe, completing his Master of Science (1989) and Ph.D. (1992) in Radiopharmaceutical Sciences from Katholieke Universiteit Leuven, Belgium—one of Europe’s premier research institutions. His graduate and doctoral research provided a strong foundation in the synthesis, radiolabeling, and biological evaluation of peptide-based radiopharmaceuticals. This multidisciplinary training combined pharmaceutical chemistry, radiochemistry, and nuclear medicine, equipping Dr. Okarvi with the tools needed to develop innovative diagnostic and therapeutic agents for oncology. His robust educational background reflects both academic excellence and deep specialization in a critical niche of medical science.

Experience:

Since 1999, Dr. Subhani M. Okarvi has served as Senior Medical Scientist and Section Head at King Faisal Specialist Hospital and Research Centre’s Cyclotron and Radiopharmaceuticals Department. He leads efforts in the synthesis, radiochemical processing, and preclinical evaluation of novel radiopharmaceuticals targeting breast, ovarian, and other cancers. His role includes supervising the production and quality control of radiotracers such as ⁹⁹ᵐTc, ⁶⁸Ga, ¹⁷⁷Lu, and ⁸⁹Zr for clinical use. Dr. Okarvi’s leadership extends to mentoring junior scientists and fostering research collaborations. His expertise spans in vitro and in vivo assays, solid-phase peptide synthesis, and regulatory aspects of radiopharmaceutical development. His work bridges the gap between laboratory innovation and bedside application, making him instrumental in advancing nuclear medicine practices in Saudi Arabia and globally.

Awards and Honors:

Dr. Subhani M. Okarvi has earned several prestigious awards and fellowships in recognition of his scientific excellence. During his doctoral studies at Katholieke Universiteit Leuven, he was awarded the Onderzoeksfonds Postgraduate Fellowship (1990–1992), a testament to his promising research trajectory. He later received the Alberta Cancer Board Fellowship (1995–1998), supporting his oncology-focused research in Canada. In 1997, he was honored with a Travel Grant from the Alberta Heritage Foundation for Medical Research, enabling international scientific exchange. These accolades highlight both his academic merit and the translational relevance of his work. His contributions continue to impact radiopharmaceutical science through groundbreaking cancer imaging and therapy innovations. These awards underscore his dedication, influence, and continued pursuit of scientific advancement in nuclear medicine.

Research Focus:

Dr. Subhani Okarvi’s research focuses on the development of novel peptide-based radiopharmaceuticals for molecular imaging and targeted radionuclide therapy. He specializes in synthesizing and radiolabeling biomolecules with isotopes such as ⁶⁸Ga, ¹⁷⁷Lu, ¹⁸F, and ⁸⁹Zr for the detection and treatment of breast, ovarian, and hypoxic tumors. His studies aim to improve the precision of PET and SPECT imaging by targeting biomarkers like estrogen receptors, Mucin1, folate receptors, and integrins. His research combines chemistry, pharmacology, and imaging sciences, leading to multiple high-impact publications and promising preclinical candidates. Dr. Okarvi is particularly invested in hybrid peptide constructs and solid-phase synthesis methods that enhance binding affinity, tumor selectivity, and in vivo stability. His work has a strong translational focus—moving lab discoveries to clinical applications. The ultimate goal is to improve early cancer diagnosis and personalize therapy using cutting-edge radiopharmaceuticals.

Publications Top Notes:

  1. 🧪 Solid-phase synthesis and in vitro and in vivo evaluation of novel Estradiol derivatives for targeting estrogen-receptor positive breast cancer (2025 – Manuscript Ready)

  2. 🧬 Preparation and preclinical evaluation of ¹⁸F-labeled folate-RGD conjugate for PET imaging of triple-negative breast carcinoma (2024 – Submitted)

  3. 🧠 Synthesis and preclinical evaluation of ⁸⁹Zr-labeled Angiotensin peptide as a breast cancer imaging agent (2024 – Abstract, Eur. J. Nucl. Med.)

  4. 🔬 Preparation, radiolabeling with ⁶⁸Ga/¹⁷⁷Lu and preclinical evaluation of novel Angiotensin peptide analog for breast cancer targeting (2023 – Pharmaceuticals)

  5. ❤️‍🔥 Development of new ⁶⁴Cu-labeled Rhodamine: A potential PET myocardial perfusion imaging agent (2022 – EJNMMI Radiopharmacy)

  6. 🎯 Synthesis, radiolabeling and preclinical evaluation of ⁶⁸Ga/¹⁷⁷Lu-labeled Leuprolide peptide analog for breast cancer detection (2022 – Cancer Biother. & Radiopharm.)

  7. 🌫️ Synthesis and in vitro and in vivo evaluation of a new ⁶⁴Cu-semicarbazone complex for hypoxic tumors (2022 – Abstract)

  8. 👩‍⚕️ Synthesis, radiolabeling and biological evaluation of ⁶⁸Ga-Mucin1 and folate hybrid peptide conjugates for ovarian cancer diagnosis (2021 – Journal of Chemistry)

  9. 🧬 Fast ¹⁸F labeling and preclinical evaluation of Mucin1-Folate hybrid peptide conjugate for targeting breast carcinoma (2021 – EJNMMI Radiopharmacy)

  10. 🧪 Preclinical evaluation of ⁶⁸Ga-NODAGA-MUC1 and its folate hybrid conjugates for breast/ovarian cancer imaging (2021 – Abstract)

Conclusion:

Dr. Subhani Mohammad Okarvi is highly suitable and strongly recommended for the Innovative Research Award.

His research in novel radiopharmaceuticals has demonstrated:

  • Significant scientific originality

  • Clear translational impact in nuclear medicine

  • Consistent academic excellence

  • Strong leadership in clinical application

With over three decades of focused, cutting-edge work in cancer-targeting agents, he exemplifies the kind of innovator the award aims to recognize. Continued support and recognition will further empower his efforts to advance personalized cancer diagnostics and therapy.

Yanhe Han | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Yanhe Han | Microbial Cell Biology | Best Researcher Award

Prof. Yanhe Han, Beijing Institute of Petrochemical Technology, China

Dr. Han Yanhe is an accomplished environmental engineer and Associate Professor at Beijing Institute of Petro-Chemical Technology, China. With over 20 years of academic and research experience, Dr. Han has focused on cutting-edge wastewater treatment technologies, such as electrochemical catalytic oxidation and micro-electrolysis. A Ph.D. graduate from Dalian University of Technology, his work bridges practical environmental challenges and sustainable engineering solutions. Internationally recognized, Dr. Han completed a research fellowship at Griffith University, Australia, expanding his global academic footprint. His research has led to over 15 high-impact publications, addressing pollutant degradation, water quality detection, and novel electrode materials. In addition to research, he teaches core subjects like water pollution control and environmental quality assessment, nurturing the next generation of environmental scientists. Dr. Han’s integrated approach to technology development and practical applications places him at the forefront of environmental research in China and globally.

Publication Profile: 

Scopus

Strengths for the Award:

  1. Innovative Research Excellence
    Dr. Han is a leader in environmental engineering, particularly in the development of electrochemical and micro-electrolysis technologies for advanced wastewater treatment. His innovations target real-world environmental challenges, such as industrial wastewater degradation, phosphorus removal, and simultaneous pollution treatment and energy recovery.

  2. Prolific Academic Output
    With over 15 peer-reviewed international publications, many in top-tier journals such as Journal of Hazardous Materials, Separation and Purification Technology, and Chemical Engineering Journal, Dr. Han has established a strong global academic presence.

  3. Interdisciplinary & Application-Oriented Work
    His research integrates environmental science, electrochemistry, and materials engineering — demonstrating a rare interdisciplinary depth and high potential for real-world application, especially in energy-efficient and sustainable water treatment systems.

  4. Global Experience & Recognition
    His research fellowship at Griffith University, Australia, reflects international collaboration and visibility, reinforcing his status as a globally competent researcher.

  5. Teaching and Mentorship
    Dr. Han is committed to education, offering over a decade of university-level teaching experience in core environmental engineering subjects, while mentoring new researchers in practical and theoretical aspects of the field.

Areas for Improvement:

  • International Research Collaboration
    While his research is impactful, greater involvement in international joint projects, EU or UN-led sustainability frameworks could amplify his global research influence.

  • Industry-Academic Partnerships
    Collaborations with industrial partners for pilot-scale or commercial deployment of his technologies could enhance technology transfer and societal impact.

  • Research Visibility and Citations
    Actively promoting his work through keynote talks, media, or open-access platforms may further boost citations and recognition.

Education:

Dr. Han Yanhe earned his Ph.D. and Master’s degrees in Environmental Engineering from the School of Environmental and Biological Science & Technology at Dalian University of Technology (2001–2006). His research focused on the electrochemically enhanced adsorption of organic pollutants using activated carbon fibers, reflecting a strong foundation in both theoretical and applied chemistry. Before that, he obtained his Bachelor’s degree in Environmental Engineering from Xi’an University of Engineering Science & Technology (1997–2001), where he gained fundamental skills in chemical processes and pollution control. His education reflects a consistent trajectory in environmental sciences, building both his research capabilities and practical engineering knowledge. These academic qualifications have shaped his expertise in advanced wastewater treatment technologies and environmental monitoring systems, forming the core of his research and professional contributions in later years.

Experience:

Dr. Han Yanhe is currently an Associate Professor at Beijing Institute of Petro-Chemical Technology (since 2011), where he leads research in electrochemical wastewater treatment and teaches environmental engineering. He was previously a Research Fellow at Griffith University, Australia (2009–2011), contributing to international research in water pollution control. From 2006 to 2009, Dr. Han served as Senior Lecturer and later Associate Professor at Liaoning Normal University. Across these roles, he has developed innovative technologies for water treatment, including internal circulation micro-electrolysis reactors and pollutant degradation methods. His leadership in both academic and research domains is evident through a strong publication record, supervision of student research, and cross-disciplinary project involvement. His international and domestic experience underscores a deep commitment to solving environmental challenges through sustainable technologies.

Research Focus:

Dr. Han Yanhe’s research centers on advanced wastewater treatment and environmental monitoring. His primary areas include electrochemical catalytic oxidation, iron-carbon micro-electrolysis, and autotrophic denitrification technologies aimed at treating industrial pollutants. He also works on real-time water quality monitoring, developing rapid detection equipment for COD, BOD, and toxicity. A notable innovation is the development of synchronous wastewater treatment and hydrogen production technologies, integrating environmental sustainability with clean energy generation. Additionally, he has contributed to the pretreatment of refractory industrial wastewater and the use of computational fluid dynamics for reactor optimization. Dr. Han’s multidisciplinary work combines chemical engineering, environmental science, and materials science, enabling the design of efficient, scalable, and eco-friendly solutions for water treatment. His focus on practical application, supported by a solid theoretical foundation, distinguishes his work in the environmental engineering field.

Publications Top Notes:

  1. Electrooxidation degradation of bisphenol A: pathways and toxicity analysis – Separation and Purification Technology, 2024

  2. Iron-carbon micro-electrolysis reactor for aniline wastewater: mechanism and pathways – Chinese Journal of Chemical Engineering, 2023

  3. Fe/C-MgCO₃ micro-electrolysis fillers for phosphorus removal – Environmental Science and Pollution Research, 2022

  4. High-efficiency PbO₂ anode via Ce-GO doping: electrochemical study – Journal pending, 2022

  5. Integrated COD and BOD determination technique – Polish Journal of Environmental Studies, 2021

  6. Sulfate removal via internal circulation iron-carbon micro-electrolysis – Separation and Purification Technology, 2021

  7. Electro-coagulation of hydrolyzed polyacrylamide: optimization study – Desalination and Water Treatment, 2020

  8. Electrochemical oxidation of HPAM at Ti/SnO₂-Sb₂O₃/β-PbO₂ Anode – Int. J. Electrochemical Science, 2020

  9. Hydrodynamic simulation in micro-electrolysis reactors – Chemical Engineering Journal, 2020

  10.  Micro-electrolysis biological fluidized bed for coking wastewater – Journal of Water Process Engineering, 2020

Conclusion:

Dr. Han Yanhe stands out as a highly qualified candidate for the Best Researcher Award. His innovative contributions in environmental engineering, particularly in wastewater treatment and electrochemical systems, are of high scientific value and societal relevance. Backed by strong academic output, international exposure, and sustained commitment to teaching, Dr. Han exemplifies the excellence this award seeks to recognize.

Halimeh Hassanpour | Plant Cell Biology | Best Academic Researcher Award

Published on by Cell Biologist

Dr. Halimeh Hassanpour | Plant Cell Biology | Best Academic Researcher Award

Dr. Halimeh Hassanpour, Aerospace Research Institute, Ministry of Science Research and Technology, Tehran, Iran, Iran

Dr. Halimeh Hassanpour is a distinguished plant physiologist and researcher at the Aerospace Research Institute, affiliated with the Ministry of Science, Research and Technology, Iran. With a Ph.D. in Plant Biology and Physiology from Kharazmi University (2012), she has emerged as a pioneer in the interdisciplinary field of plant space biology. Her research uniquely integrates plant physiology, biotechnology, and environmental stress responses, with a special focus on microgravity and spaceflight conditions. Dr. Hassanpour has led numerous industrial and academic projects involving medicinal plants, algae, and nanoparticles, producing over 40 peer-reviewed articles in SCI/Scopus-indexed journals. She is the author of a notable book on plant responses to gravity and has significantly contributed to space-oriented biological research in Iran. Her Google Scholar citation count exceeds 780, demonstrating the relevance and impact of her work globally. Dr. Hassanpour stands as a leader in advancing sustainable solutions for agriculture and pharmaceuticals in extreme environments.

Publication Profile: 

Google Scholar

Orcid

Strength of the Awards:

  1. Interdisciplinary Expertise: Dr. Hassanpour has successfully bridged plant physiology with space biology—an emerging and globally significant research domain.

  2. High Impact Research: With 781 citations on Google Scholar and publications in SCI/Scopus-indexed journals, her research has gained wide academic recognition.

  3. Innovative Focus Areas:

    • Stress physiology in medicinal plants

    • Plant responses to microgravity, magnetic fields, and nanoparticles

    • Secondary metabolite enhancement in in vitro and space-simulated environments

  4. Applied Industrial Collaborations: She has led industry-driven projects with measurable outcomes, such as optimizing astaxanthin production from algae and Capsicum growth under controlled lighting.

  5. Authorship of a Specialized Book: Her 2019 book on gravity and plant response mechanisms reflects a leadership role in space-biology research.

  6. Prolific Output: Over 20 peer-reviewed publications, with strong citation counts (e.g., 80, 69, 63), and active contributions to journals like BMC Plant Biology, Scientific Reports, and Journal of Space Science and Technology.

Areas for Improvement:

  1. Global Outreach: While her work is innovative, participation in international collaborations and space biology networks would enhance visibility.

  2. Commercialization Strategy: More focus on translational research or tech transfer (e.g., patents, startup ventures) could extend the impact beyond academic circles.

  3. Patent Portfolio: Although her work has application potential, published patents or filings would further validate industrial relevance.

Education:

Dr. Hassanpour earned her Ph.D. in Plant Biology and Physiology from Kharazmi University of Iran in 2012. Her doctoral research focused on physiological and biochemical responses of medicinal plants to abiotic stresses such as salinity, drought, and magnetic fields. Prior to her Ph.D., she obtained a Master’s and Bachelor’s degree in Plant Sciences, with a focus on the mechanisms of plant stress adaptation. During her academic journey, she specialized in advanced plant tissue culture, molecular biology, enzymology, and stress physiology techniques. Her education provided the foundation for her pioneering work in plant space biology—especially how plants respond to microgravity, clinorotation, and magnetic stimuli. Her interdisciplinary academic background has uniquely positioned her to bridge the gap between plant sciences and aerospace research, making her an expert in developing stress-resilient plants for space and extreme Earth environments.

Experience:

Dr. Halimeh Hassanpour currently serves as a senior researcher and faculty member at the Aerospace Research Institute, Ministry of Science, Research, and Technology in Iran. With over a decade of professional experience, she has worked extensively on national and industrial projects, particularly in plant tissue culture, algae biotechnology, and plant responses to environmental stressors. She collaborates with pharmaceutical and agricultural industries, including Karandishan Company and Rezvan Molay Garden Company, optimizing plant production under controlled and stress-simulated environments. Her expertise includes designing bioreactor systems, evaluating oxidative stress biomarkers, and studying gene expression under unique space-simulated conditions. She has also authored a scientific book and serves as a consultant on space biology for plant-based life support systems. Her multi-sectoral experience blends research excellence with real-world applications in agriculture, pharmaceuticals, and space sciences, showcasing her as an influential contributor to both academia and industry.

Research Focus:

Dr. Hassanpour’s research lies at the intersection of plant space biology, stress physiology, and biotechnology. She investigates how medicinal and edible plants adapt to abiotic stress conditions such as low atmospheric pressure, magnetic fields, microgravity, and nanoparticles, mimicking space or harsh terrestrial environments. A key theme of her work involves optimizing plant and algae cultures for pharmaceutical compound production, like astaxanthin from Haematococcus algae or physalins from Physalis alkekengi. She employs tools such as in vitro tissue culture, clinorotation, spectroscopy, and gene expression analysis to study the modulation of antioxidant defense mechanisms, nitric oxide pathways, and DNA methylation under stress. Her findings contribute to the development of resilient plant systems for space missions, controlled-environment agriculture (CEA), and phytopharmaceutical applications. With broad applications in both the space and health industries, her research bridges fundamental biology with innovative technologies aimed at sustainability and health improvement.

Publications Top Notes:

  1. 🌶️ Red light induced seed germination and seedling growth in Capsicum frutescens – BMC Plant Biology, 2025

  2. 🧫 Effect of low atmospheric pressure on Dunaliella salina – Journal of Space Science and Technology, 2024

  3. 🍒 Optimized Physalis alkekengi callus culture for nitric oxide and antioxidants – Scientific Reports, 2024

  4. 🧪 ROS regulation in Dunaliella salina via fulvic acid – Journal of Applied Phycology, 2024

  5. 🧲 Cell suspension culture of Physalis under static magnetic field – Protoplasma, 2024

  6. 🌿 Hyoscyamus niger under clinorotation: alkaloids & gene expression – Protoplasma, 2024

  7. 🌊 SiO2 nanoparticles in Spirulina platensis: enzyme & metabolite response – Plant Process and Function, 2024

  8. 🚀 Simulated microgravity enhancing secondary metabolism in Physalis – Acta Physiologiae Plantarum, 2023

  9. 🧲 Overview of magnetic field effects on plant physiology – Iranian Journal of Plant Physiology, 2023

  10. ⚙️ Iron oxide nanoparticles and antioxidant response in Physalis – Russian Journal of Plant Physiology, 2023

Conclusion:

Dr. Halimeh Hassanpour is a highly suitable candidate for the Best Academic Researcher Award. Her original contributions in space plant biology, environmental stress physiology, and plant biotechnology have placed her among the leaders in a niche but rapidly growing field. With her continued output, interdisciplinary integration, and innovative research direction, she exemplifies the qualities of a world-class academic researcher deserving of recognition.

Amr Hanbali | Therapeutic use of Cellular therapy in cancer treatment | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Amr Hanbali | Therapeutic use of Cellular therapy in cancer treatment | Best Researcher Award

Assoc. Prof. Dr. Amr Hanbali | King Faisal Specialist Hospital & Research Center | Saudi Arabia

Dr. Amr AlHanbali is a dual-certified Hematology and Oncology consultant with over 18 years of experience in malignant and benign hematological conditions. Based at King Faisal Specialist Hospital & Research Center in Riyadh, Saudi Arabia, he specializes in hematologic malignancies and stem cell transplantation. Dr. AlHanbali previously served as a senior staff physician and Associate Fellowship Program Director at Henry Ford Health System in Detroit, Michigan. Recognized for his academic involvement, he holds teaching appointments at Wayne State University and Alfaisal University. Known for his dedication to clinical mentorship, he has trained numerous medical students, residents, and fellows. He is actively involved in research and is a member of several prestigious medical organizations including the American Society of Hematology and American Society of Clinical Oncology. With expertise ranging from bone marrow procedures to managing complex hematologic disorders, Dr. AlHanbali is a respected leader in the field of hematology and stem cell transplantation.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Research Contribution

    • Over 17 peer-reviewed publications, including impactful case reports, national guidelines, and original research in hematology, oncology, and stem cell transplantation.

    • Active contributor to national guidelines on multiple myeloma, reflecting leadership in shaping national healthcare standards in KSA.

  2. Dual Academic and Clinical Roles

    • Combines academic excellence (as faculty at Wayne State University and Alfaisal University) with hands-on clinical expertise at a premier institution (King Faisal Specialist Hospital & Research Center).

  3. Innovative Focus in Hematology and Transplantation

    • Research into underexplored areas such as hepatitis B reactivation post-rituximab, genetic donor match outcomes, and therapies for AL amyloidosis.

  4. International Exposure and Leadership

    • Experience across the U.S. and Saudi Arabia, influencing programs in both systems.

    • Played a key role in training and selecting future hematology-oncology fellows in the U.S.

  5. Mentorship and Capacity Building

    • Mentored numerous trainees, enhancing research culture among younger clinicians.

Areas for Improvement:

  1. Higher Impact Publications Needed

    • While the volume and variety of research are commendable, more publications in top-tier journals (NEJM, Lancet, Blood, JCO) could boost citation impact and visibility.

  2. Research Grants and Collaborative Trials

    • Pursuing multicenter studies, international collaborations, or industry-sponsored clinical trials would further elevate his profile and expand research funding sources.

  3. Technological Innovation/Patents

    • Exploring biotech innovation, AI in diagnostics, or cellular therapy patents could position him among the top medical innovators.

Education:

Dr. Amr AlHanbali completed his Bachelor of Medicine and Surgery from the University of Jordan in 1999. He pursued medical training in the United States, starting with an internal medicine residency (2001–2004) at Henry Ford Health System, Detroit. He continued his specialization with a fellowship in Hematology and Oncology (2004–2007) at the same institution. During his training, he also undertook elective rotations in Pediatric Cardiology and Gastroenterology at the University of Texas Medical Branch, Galveston, further enriching his academic exposure. He is certified by the American Board of Internal Medicine in Internal Medicine (2004), Hematology (2007), and Oncology (2007). Dr. AlHanbali holds academic titles as a Clinical Assistant Professor at Wayne State University, Detroit, and Adjunct Associate Professor at Alfaisal University, Riyadh. His educational background reflects a strong foundation in internal medicine, with a deep focus on hematology and oncology, further supported by teaching and research excellence.

Experience:

Dr. AlHanbali’s clinical career spans over 18 years, currently serving as Hematology and Stem Cell Transplant Consultant at King Faisal Specialist Hospital & Research Center in Riyadh since 2013. Prior to this, he held multiple leadership roles at Henry Ford Health System, Detroit, including Senior Staff Physician and Associate Fellowship Program Director (2007–2013). His medical expertise covers the diagnosis and treatment of a wide range of hematologic malignancies such as leukemia, lymphoma, multiple myeloma, and myeloproliferative disorders. Dr. AlHanbali also has extensive experience in stem cell transplantation, intrathecal chemotherapy, and bone marrow biopsy. He has been instrumental in resident selection and curriculum development for fellowship programs in hematology and oncology. His work bridges clinical excellence with academic mentorship, guiding numerous trainees and junior physicians. In addition to patient care, he is involved in clinical guideline development and research, particularly in the field of multiple myeloma and transplant outcomes.

Research Focus:

Dr. Amr AlHanbali’s research is centered on hematologic malignancies, particularly multiple myeloma, lymphoma, leukemia, and stem cell transplantation. His work explores novel therapeutic approaches, transplant outcomes, disease progression, and treatment-related complications. He has contributed significantly to research on hepatitis B reactivation, chemotherapy-induced toxicities, and the protective role of comorbidities like diabetes in cancer metastasis. As an active member of the Saudi Myeloma Working Group, he has co-authored national guidelines for both newly diagnosed and relapsed/refractory multiple myeloma. His studies also examine health disparities in cancer care, including outcomes among African American populations and the impact of familial genetics in donor matches. With over a dozen peer-reviewed publications and case reports in high-impact journals, Dr. AlHanbali continues to push forward understanding in clinical hematology and oncology. He combines bedside insights with academic rigor to shape evidence-based practice and improve treatment outcomes in cancer and transplant medicine.

Publications Top Notes:

  1.  Mediastinal Hematoma With SVC Syndrome From A Central Venous Catheter Insertion – CHEST, 2003

  2.  Diabetes Has Protective Effect Against Metastasis in Non-Small Cell Lung Cancer – Arch Intern Med, 2007

  3.  Delayed Hepatitis B Viral Replication Post-Rituximab & Fludarabine in Waldenstrom Macroglobulinemia – Am J Hematol, 2007

  4.  Acute Pancreatitis Induced by Adult Precursor B-cell ALL – South Med J, 2007

  5.  Hypersensitivity Reaction of Mylotarg with Platelet Transfusion – Am J Health Syst Pharm, 2007

  6.  Incidence of Hepatitis B Reactivation after Rituximab Therapy – Am J Hematol, 2009

  7. Outcomes After Auto-SCT in African Americans with Multiple Myeloma – Bone Marrow Transplant, 2009

  8.  HER-2 Status May Change in Recurrent Breast Cancer – Cancer Research, 2009

  9.  Compartment Syndrome as Presentation of Chronic Myelogenous Leukemia – J Gen Intern Med, 2010

  10.  Use of Insulin and its Effect on Survival in NSCLC – J Clin Oncol, 2009

Conclusion:

Dr. Amr AlHanbali demonstrates a stellar blend of clinical expertise, research productivity, academic mentorship, and leadership in hematology and oncology. His research contributions have practical implications in areas such as multiple myeloma, leukemia, transplant immunology, and chemotherapy safety.

He is highly deserving of recognition and stands out as a top contender for a Best Researcher Award, particularly in the categories of clinical research excellence, translational hematology, and medical education integration with research.

Balasubramanian Murugesan | Cell Surface Receptors | Best Researcher Award

Published on by Cell Biologist

Dr. Balasubramanian Murugesan | Cell Surface Receptors | Best Researcher Award

Dr. Balasubramanian Murugesan, K.S.Rangasamy College of Arts and Science (Autonomous), Tamilnadu State, India, India

Dr. M. Balasubramanian, M.Phil., Ph.D., SET, is an accomplished Indian researcher and educator specializing in microbiology, enterobacterial infections, molecular biology, and lichen-based bioprospective studies. Born on May 17, 1984, he brings over 14 years of cumulative experience in academia and industry. His expertise spans molecular simulations and therapeutic compound discovery from natural sources, particularly lichens. With a strong foundation in life sciences and teaching biotechnology at both UG and PG levels, Dr. Balasubramanian is committed to nurturing scientific inquiry and translational research. He is actively involved in advanced drug discovery using in silico techniques and has published widely in SCOPUS and Web of Science-indexed journals. His interdisciplinary work, particularly in evaluating the biomedical potential of foliose lichens, has earned him professional recognition. As a life member of various academic societies, he continues to contribute to global biosciences with impactful teaching, research, and innovation.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Multidisciplinary Expertise
    Dr. Balasubramanian’s research spans across core areas of modern biosciences, including microbiology, molecular biology, bioinformatics, phytochemistry, and computational simulations. His work contributes directly to combating infectious diseases and cancer therapeutics.

  2. Outstanding Research Contributions
    With over 11 peer-reviewed publications, many in SCOPUS, Web of Science, and SCI-indexed journals, he has explored novel bioactive compounds from lichens and plants. His recent in silico study on usnic acid as a potential anti-cancer agent showcases the translational relevance of his research.

  3. Academic & Industrial Experience
    Accumulating 14+ years of combined teaching and industrial experience, he has shaped student careers while applying his knowledge in practical settings — a rare blend of academic insight and applied research.

  4. Award-Winning Track Record & Recognitions

    • Ranked 8th in B.Sc. Microbiology by Periyar University

    • Completed NITTTR training on Biotechnology & Biomedical Engineering

    • Holder of a Certificate of Excellence, recognizing his research quality and productivity

  5. Membership in Professional Bodies
    Active life member in five national and international organizations, such as the Indian Microbiology Society, Indian Lichenological Society, and the International Association of Engineers, reflecting his professional network and scientific credibility.

Areas for Improvement:

  1. Grant Acquisition and Funding Visibility
    There is limited data on participation in externally funded research projects. Securing national/international research grants could further elevate the impact and scope of his research.

  2. International Collaborations
    While his research is impactful, collaboration with global institutions could enhance visibility and provide broader application and funding opportunities.

  3. Technology Transfer and Patents
    Patenting and product commercialization of the bioactive compounds explored (like lichen-derived anti-cancer agents) would strengthen the applied dimension of his research.

Educational Qualifications:

Dr. Balasubramanian’s educational background showcases academic distinction across microbiology and biotechnology. He earned his B.Sc. in Microbiology from Periyar University, securing the 8th rank in March 2004. Following this, he pursued an M.Phil. in Biotechnology from Periyar University in 2008, completing it with First Class (68%). His academic journey culminated with a Ph.D. in Biotechnology (Animal Biotechnology specialization) from Bharathiar University, Coimbatore, in 2015, where his research focused on in vitro, in silico, and in vivo biomedical applications of foliose lichens. Additionally, he qualified the State Eligibility Test (SET) conducted by Mother Teresa Women’s University, Kodaikanal, in 2016. His solid academic credentials are supported by his deep-rooted interest in microbial pathogenesis, pharmacological studies, and computational biology. Dr. Balasubramanian’s education has laid a firm foundation for his prolific research and impactful academic career.

Professional Experience:

With 13 years and 6 months of teaching experience and 1 year and 2 months in industry, Dr. Balasubramanian has a rich, multidisciplinary background. He began as a Lecturer at Vivekanandha College for Women, Tiruchengode (2007–2008), teaching undergraduate and postgraduate biotechnology students. He later served as an Assistant Professor at SSM College of Arts and Science, Komarapalayam (2009–2010), handling core UG biotechnology subjects. His cumulative experience of over 14 years blends academic excellence with industry-relevant applications. His teaching is research-oriented, focusing on molecular biology, drug development, and microbiology. Apart from classroom instruction, he has supervised numerous student projects, engaged in scientific collaborations, and developed educational resources. Dr. Balasubramanian’s career reflects a commitment to fostering scientific curiosity and research skills among students, while also contributing significantly to applied biomedical research in academia.

Awards and Honors:

Dr. M. Balasubramanian has earned multiple recognitions for his academic and research excellence. He achieved the 8th Rank in B.Sc. Microbiology from Periyar University (2004), marking early academic distinction. He completed a short-term training course on “Biotechnology and Biomedical Engineering” at NITTTR, Chandigarh in 2008, conducted by the Ministry of HRD, Government of India. He has been honored with a Certificate of Excellence for his impactful scientific contributions, reflecting peer recognition for his ongoing commitment to biotechnology. He is also a Life Member of respected organizations including the Indian Lichenological Society, International Association of Engineers (UK), Indian Microbiology Society, and others. These memberships affirm his standing in the global scientific community. Dr. Balasubramanian’s recognition stems from his interdisciplinary research in natural compound therapeutics, molecular dynamics, and microbial pharmacology, qualifying him as a top candidate for research awards in his field.

Research Focus:

Dr. Balasubramanian’s research is focused on the biomedical potential of natural compounds, especially foliose lichens, using in vitro, in vivo, and in silico methodologies. His Ph.D. work involved extensive analysis of Sticta weigelii, Dermatocarpon vellereum, and Heterodermia boryi for their pharmacological efficacy. He explores molecular docking and dynamic simulations to assess ligand interactions with cancer and microbial proteins—particularly relevant in oncology and antimicrobial therapy. He is also deeply engaged in microbial diversity studies, bioprospection, and green synthesis of bioactive compounds from plants and lichens. His interdisciplinary methods integrate microbiology, pharmacology, computational biology, and plant chemistry, producing findings that have appeared in SCOPUS and Web of Science journals. Recent studies include targeting cervical cancer proteins using lichen-derived molecules. His translational research approach aims to bridge traditional medicine with modern biotechnology, contributing to novel drug development and therapeutic strategies in healthcare.

Publications Top Notes:

  1. 🧪 Salivary analysis of reative oxygen species in OSF and OSCC patients – Int. J. Biosci. (2012)

  2. 🧬 Effect of α-tocopherol on salivary ROS in oral submucous fibrosis – Ann. Clin. Biochem. (2012)

  3. 🌳 Genetic diversity in Acacia constricta and Acacia farnesiana – Int. J. Med. Res. (2012)

  4. 🌿 Phytochemical screening and antibacterial activity of Nyctanthes arbor-tristis – J. Chem. Pharm. Res. (2012)

  5. 🦠 Antimycobacterial activity of foliose lichens – Int. J. Pharm. Sci. Res. (2014)

  6. 🌱 Antioxidant properties of foliose lichens – J. Chem. Pharm. Res. (2014)

  7. 💊 Pharmacological study of Flavoparmelia caperata for analgesic use – IOSR J. Pharm. (2018)

  8. 🧫 In vitro and in vivo study on foliose lichens for biomedical uses – Int. Interdisciplinary Res. J. (2018)

  9. 🌾 Secondary metabolites and anticancer activity of Azadirachta indica – J. Appl. Sci. Comp. (2019)

  10. 📚 Review of pharmaceutical uses of Heliotropium genus – Eur. J. Pharm. Med. Res. (2020)

 

Conclusion:

Dr. M. Balasubramanian’s extensive work in the discovery of natural bioactive compounds, especially his interdisciplinary research into cancer therapeutics using lichens and computational biology, represents an exemplary model of innovation in life sciences. His strong academic foundation, consistent publishing record, and societal relevance of research make him highly deserving of the Best Researcher Award. With further international collaboration and grant-funded projects, he is poised to become a thought leader in biomedical biotechnology.

Kwaghgba Elijah Gbabe | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Dr. Kwaghgba Elijah Gbabe | Cell Structure Analysis | Best Researcher Award

Dr. Kwaghgba Elijah Gbabe | Nigerian Stored Products Research Institute | Nigeria

Engr. Dr. Kwaghgba Elijah Gbabe is a seasoned Senior Research Officer at the Nigerian Stored Products Research Institute (NSPRI), Ilorin, Nigeria. With over nine years of progressive research experience, he specializes in food processing, postharvest technology, and agricultural nanotechnology. He is a trailblazer in developing electrospun hexanal nanofiber matrices aimed at extending the shelf-life of fruits such as bananas, mangoes, and tomatoes. His research integrates innovative preservation technologies to enhance food quality and sustainability. A COREN-certified engineer and postgraduate fellow, Dr. Gbabe has collaborated internationally, notably with the Centre for Agricultural Nanotechnology in India. With extensive publications and conference contributions, he is an advocate of research-driven food security and sustainable packaging. He brings a multidisciplinary edge to the evolving field of agricultural innovation, focusing on reducing postharvest losses and increasing storage efficiency in sub-Saharan Africa.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Innovative Research in Agricultural Nanotechnology

    • Pioneered the development of electrospun hexanal nanofiber matrices for fruit shelf-life extension — an emerging and impactful technology in food preservation.

  2. Strong Publication Record 

    • Over a dozen peer-reviewed journal articles and conference papers published across international and national platforms with DOIs, indicating high-quality scholarly contribution.

  3. Hands-On International Collaboration 

    • Completed a research internship at TNAU, India, and collaborated with renowned global experts like Prof. K.S. Subramanian in nanoscience.

  4. Multi-disciplinary Skills 

    • Expertise in advanced instrumentation (FTIR, GC-MS, SEM, TEM) and statistical tools (R, SPSS) shows broad technical competence.

  5. Real-world Application & Societal Impact 

    • Focuses on postharvest technologies to reduce food losses, enhance food safety, and support smallholder farmers and artisans.

  6. Leadership and Mentorship

    • Supervises junior staff, fabricators, and trainees, and contributes to capacity building through training workshops.

  7. Recognized Academic Achievement 

    • Recipient of the Benue State University Postgraduate Fellowship (2020–2025).

Areas for Improvement:

  1. Technology Commercialization and Patenting

    • While research output is strong, translating research into commercial products or patents could increase impact.

  2. Broader International Visibility

    • Participation in more international consortia or grants (e.g., EU Horizon, USAID, FAO) could elevate the global footprint.

  3. Expanded Multidisciplinary Outreach

    • Could integrate more with biotech and AI in agri-research, especially in smart packaging and AI-driven postharvest solutions.

Education:

Dr. Gbabe is currently pursuing his Ph.D. in Food Processing and Technology at Benue State University, Makurdi (2020–2025), with a research focus on developing electrospun hexanal nanofiber matrices for fruit preservation. He holds a Master of Engineering in Agricultural and Environmental Engineering from the University of Agriculture, Makurdi (2017–2019), where his thesis explored eco-building materials using rice husk and sawdust. His undergraduate and professional training background is further enhanced by a Certificate in Computer Appreciation (2010), an internship at the Centre for Agricultural Nanotechnology, TNAU, India (2023), and registration with COREN (2024). Dr. Gbabe is also a member of the Nigerian Institution of Agricultural Engineers (NIAE-M2207), demonstrating a strong foundation in both academic knowledge and regulatory standards in engineering and food technology. His educational pursuits reflect a consistent drive toward sustainability, innovation, and technological adaptation in agricultural systems.

Experience:

Dr. Gbabe serves as a Senior Research Officer at NSPRI since 2016, where he leads projects on postharvest technology, storage engineering, and food shelf-life enhancement. His duties span experimental design, research data analysis, technical report writing, equipment fabrication supervision, and stakeholder training. He has been instrumental in developing novel postharvest technologies and electrospun hexanal nanofiber matrices for fruit preservation. In 2023, he completed a research internship at the Centre for Agricultural Nanotechnology, TNAU, India, gaining hands-on experience in nanotoxicity, food nanotechnology, and biosafety. Dr. Gbabe is known for his interdisciplinary collaboration, capacity-building initiatives, and extensive field and lab-based research. He also coordinates training programs for artisans, farmers, and students. His rich professional journey is marked by impactful project execution, community-focused technology dissemination, and consistent contributions to national and international research publications.

Research Focus:

Dr. Gbabe’s research is centered on postharvest loss reduction, sustainable food preservation, and agricultural nanotechnology. He is pioneering the use of electrospun hexanal nanofiber matrices to extend the shelf-life of perishable fruits like bananas, mangoes, and tomatoes—a major advancement in food storage technology. His work addresses the chemical and biological challenges in postharvest handling, integrating advanced techniques such as FTIR, GC-MS, SEM, and TEM to monitor quality and degradation. He is also exploring green materials for packaging and eco-friendly building solutions using agricultural waste like rice husks and sawdust. His international collaboration with TNAU, India, expanded his research in nanotoxicity and food safety. With a focus on experimental design, interdisciplinary innovation, and practical application, Dr. Gbabe contributes to the development of scalable, cost-effective technologies tailored for African agricultural ecosystems. His goal is to enhance food security through intelligent preservation methods and sustainable postharvest engineering.

Publication Top Notes:

  1.  Effect of Hexanal Nano-fiber Matrix on Quality Parameters of Tomato Fruits during Storage

  2.  Development of Novel Hexanal Nano-fibre Matrix by Electrospinning for Shelf-life Extension of Mango Fruits

  3.  Implication of Different Storage Techniques on Physical Attributes of African Okra (Abelmoschus esculentus)

  4.  Maize Grains Milling Efficiency: A Performance Analysis of a Hammer Mill

  5.  Insecticidal and Toxicity Studies of Heliotropium Indicum Leaf Extracts for Stored Grain Pest Control

  6.  Commercial Utilization of Inert Atmosphere Silo for Maize Storage

  7.  Chemical and Physico-chemical Properties of OFSP Chips Dried Using Solar Dryers

  8.  Evaluation of the Use of Rice Husk in Producing Eco-Building Materials

  9.  Pros and Cons of AI Thermal Imaging in Postharvest Handling of Agricultural Products

  10.  Development of Hexanal Electrospun Nano-fiber Matrix for Banana Preservation

Conclusion:

Engr. Dr. Kwaghgba Elijah Gbabe is an exemplary researcher who combines scientific rigor, technological innovation, and practical application in the field of food systems and agricultural engineering. His pioneering work in nanotechnology, coupled with his leadership in postharvest technology, makes him exceptionally deserving of the Best Researcher Award.